{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:40:03Z","timestamp":1787499603035,"version":"build-2736575974"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFC3600201"],"award-info":[{"award-number":["2022YFC3600201"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology Cardiovascular Risk and Prevention"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ijcrp.2025.200527","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T19:56:13Z","timestamp":1760558173000},"page":"200527","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Recurrent device-related thrombosis after left atrial appendage closure with the watchman FLX: A case report and literature review"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-4366-6290","authenticated-orcid":false,"given":"Yuemiao","family":"Jiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyuan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-9650-4978","authenticated-orcid":false,"given":"Chengqian","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcrp.2025.200527_bib1","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ijcard.2021.09.051","article-title":"Long-term outcome of left atrial appendage occlusion with multiple devices","volume":"344","author":"Radinovic","year":"2021","journal-title":"Int. J. Cardiol."},{"issue":"12","key":"10.1016\/j.ijcrp.2025.200527_bib2","first-page":"1629","article-title":"Incidence and clinical impact of device-related thrombus following percutaneous left atrial appendage occlusion","volume":"4","author":"Alkhouli","year":"2018","journal-title":"JACC (J. Am. Coll. Cardiol.): Clinical Electrophysiology"},{"issue":"18","key":"10.1016\/j.ijcrp.2025.200527_bib3","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1161\/CIRCULATIONAHA.120.050117","article-title":"On behalf of the PINNACLE FLX investigators. Primary outcome evaluation of a next-generation left atrial appendage closure device: results from the PINNACLE FLX trial","volume":"143","author":"Kar","year":"2021","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ijcrp.2025.200527_bib4","first-page":"96","article-title":"Incidence, predictors, and clinical outcomes of device-related thrombus in the amulet IDE trial","volume":"9","author":"Schmidt","year":"2023","journal-title":"JACC (J. Am. Coll. Cardiol.): Clinical Electrophysiology"},{"issue":"14","key":"10.1016\/j.ijcrp.2025.200527_bib5","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.jacc.2018.01.076","article-title":"Device-related thrombosis after percutaneous left atrial appendage occlusion for atrial fibrillation","volume":"71","author":"Fauchier","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"issue":"11","key":"10.1016\/j.ijcrp.2025.200527_bib6","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1007\/s00392-022-02065-4","article-title":"Clinical and echocardiographic risk factors for device-related thrombus after left atrial appendage closure: an analysis from the multicenter EUROC-DRT registry","volume":"111","author":"Vij","year":"2022","journal-title":"Clin. Res. Cardiol."},{"key":"10.1016\/j.ijcrp.2025.200527_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2025.133385","article-title":"Routine preoperative transthoracic echocardiography for predicting incomplete endothelialization of the watchman left atrial appendage occluder: a single-center five-year study","volume":"435","author":"Yu","year":"2025","journal-title":"Int. J. Cardiol."},{"issue":"21","key":"10.1016\/j.ijcrp.2025.200527_bib8","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1016\/j.jcin.2022.09.001","article-title":"Peridevice leak after transcatheter left atrial appendage occlusion","volume":"15","author":"Price","year":"2022","journal-title":"JACC Cardiovasc. Interv."},{"issue":"1","key":"10.1016\/j.ijcrp.2025.200527_bib9","doi-asserted-by":"crossref","first-page":"42","DOI":"10.15420\/icr.2018.21.3","article-title":"Device-related thrombus after left atrial appendage closure","volume":"14","author":"Garot","year":"2019","journal-title":"Intervent Cardiol."},{"issue":"11","key":"10.1016\/j.ijcrp.2025.200527_bib11","doi-asserted-by":"crossref","first-page":"e718","DOI":"10.4244\/EIJ-D-23-00802","article-title":"Long-term cardiac computed tomography Follow-up after left atrial appendage occlusion","volume":"20","author":"Tiroke","year":"2024","journal-title":"EuroIntervention"},{"issue":"3","key":"10.1016\/j.ijcrp.2025.200527_bib12","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1007\/s11239-020-02205-5","article-title":"Detailed thrombogenicity phenotyping and 1 year outcomes in patients undergoing watchman implantation: (target-watchman) a case\u2013control study","volume":"50","author":"Sherwood","year":"2020","journal-title":"J. Thromb. Thrombolysis"},{"issue":"12","key":"10.1016\/j.ijcrp.2025.200527_bib13","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.jacep.2017.05.006","article-title":"Incidence, characteristics, and clinical course of device-related thrombus after watchman left atrial appendage occlusion device implantation in atrial fibrillation patients","volume":"3","author":"Kubo","year":"2017","journal-title":"JACC Clin Electrophysiol"},{"issue":"5","key":"10.1016\/j.ijcrp.2025.200527_bib14","article-title":"Device-related thrombus after left atrial appendage closure: data on thrombus characteristics, treatment strategies, and clinical outcomes from the EUROC-DRT-Registry","volume":"14","author":"Sedaghat","year":"2021","journal-title":"Circ: Cardiovascular Interventions"},{"issue":"6","key":"10.1016\/j.ijcrp.2025.200527_bib15","article-title":"Unforeseen and immediate: a case of a post-watchman device-related thrombus","volume":"16","author":"Sethi","year":"2024","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.ijcrp.2025.200527_bib16","article-title":"Percutaneous extraction of a large device-related thrombus on a WatchmanTM device: a case report","volume":"6","author":"Vyas","year":"2021","journal-title":"Eur Heart J Case Rep"},{"issue":"1","key":"10.1016\/j.ijcrp.2025.200527_bib17","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.amjcard.2017.03.253","article-title":"Changes in coagulation and platelet activation markers following transcatheter left atrial appendage closure","volume":"120","author":"Rod\u00e9s-Cabau","year":"2017","journal-title":"Am. J. Cardiol."},{"issue":"6","key":"10.1016\/j.ijcrp.2025.200527_bib18","first-page":"490","article-title":"Device-related thrombosis on atrial septal defect occluder after simultaneous closure of left atrial appendage and atrial septal defect: a case report","volume":"16","author":"He","year":"2019","journal-title":"J Geriatr Cardiol"},{"issue":"11","key":"10.1016\/j.ijcrp.2025.200527_bib19","article-title":"Challenges and insights in managing device-related thrombosis Post-WATCHMAN implantation: a case report of surgical thrombectomy in an elderly jehovah's witness patient with atrial fibrillation","volume":"15","author":"Tsukioka","year":"2023","journal-title":"Cureus"},{"issue":"9","key":"10.1016\/j.ijcrp.2025.200527_bib20","article-title":"Late-onset left atrial appendage occlusion device-related thrombus attributed to mitral bioprosthetic stenosis: a case report","volume":"8","author":"Rana","year":"2024","journal-title":"Eur Heart J Case Rep"},{"issue":"5","key":"10.1016\/j.ijcrp.2025.200527_bib21","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.ahj.2006.02.005","article-title":"The protect af (watchman left atrial appendage system for embolic PROTECTion in patients with atrial fibrillation) trial","volume":"151","author":"Fountain","year":"2006","journal-title":"Am. Heart J."},{"issue":"6","key":"10.1016\/j.ijcrp.2025.200527_bib22","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1161\/CIRCULATIONAHA.112.114389","article-title":"Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-year Follow-up of the protect af (watchman left atrial appendage system for embolic protection in patients with atrial fibrillation) trial","volume":"127","author":"Reddy","year":"2013","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ijcrp.2025.200527_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","article-title":"Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial","volume":"64","author":"Holmes","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcrp.2025.200527_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2023.08.010","article-title":"Network meta-analysis of initial antithrombotic regimens after left atrial appendage occlusion","author":"Carvalho","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcrp.2025.200527_bib25","article-title":"Closure device-related thrombosis after anticoagulation with dabigatran in patients undergoing percutaneous left atrial appendage closure: case reports and literature review","volume":"11","author":"Li","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"23","key":"10.1016\/j.ijcrp.2025.200527_bib26","article-title":"Off-label reduced-dose apixaban does not reduce hemorrhagic risk in Taiwanese patients with nonvalvular atrial fibrillation: a retrospective, observational study","volume":"100","author":"Chen","year":"2021","journal-title":"Medicine (Baltim.)"},{"issue":"19","key":"10.1016\/j.ijcrp.2025.200527_bib27","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1161\/CIRCULATIONAHA.123.065614","article-title":"Associations of apixaban dose with safety and effectiveness outcomes in patients with atrial fibrillation and severe chronic kidney disease","volume":"148","author":"Xu","year":"2023","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ijcrp.2025.200527_bib28","first-page":"335","article-title":"Resolution of left ventricular thrombus with apixaban in a patient with hypertrophic cardiomyopathy","volume":"44","author":"Kaya","year":"2016","journal-title":"Turk Kardiyol. Dernegi Arsivi"},{"issue":"2","key":"10.1016\/j.ijcrp.2025.200527_bib29","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJMoa2401918","article-title":"Transcatheter valve replacement in severe tricuspid regurgitation","volume":"392","author":"Hahn","year":"2025","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.ijcrp.2025.200527_bib30","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jacc.2024.10.067","article-title":"TRISCEND II pivotal trial investigators. Quality of life after transcatheter tricuspid valve replacement: 1-year results from TRISCEND II pivotal trial","volume":"85","author":"Arnold","year":"2025","journal-title":"J. Am. Coll. Cardiol."},{"issue":"3","key":"10.1016\/j.ijcrp.2025.200527_bib31","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jacc.2024.10.071","article-title":"Transcatheter tricuspid valve replacement","volume":"85","author":"Hausleiter","year":"2025","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcrp.2025.200527_bib32","article-title":"Combinatorial biomedicine: a novel discipline","volume":"727","author":"Hu","year":"2024","journal-title":"ESS Open Archive eprints"},{"key":"10.1016\/j.ijcrp.2025.200527_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121208","article-title":"Surface modification to enhance cell migration on biomaterials and its combination with 3D structural design of occluders to improve interventional treatment of heart diseases","volume":"279","author":"Shen","year":"2021","journal-title":"Biomaterials"},{"issue":"23","key":"10.1016\/j.ijcrp.2025.200527_bib34","article-title":"UV-Triggered hydrogel coating of the double network polyelectrolytes for enhanced endothelialization","volume":"11","author":"Wang","year":"2024","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.ijcrp.2025.200527_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122769","article-title":"Tailored extracellular matrix-mimetic coating facilitates reendothelialization and tissue healing of cardiac occluders","volume":"313","author":"Qin","year":"2025","journal-title":"Biomaterials"}],"container-title":["International Journal of Cardiology Cardiovascular Risk and Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772487525001655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772487525001655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T20:01:13Z","timestamp":1773950473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772487525001655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":34,"alternative-id":["S2772487525001655"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcrp.2025.200527","relation":{},"ISSN":["2772-4875"],"issn-type":[{"value":"2772-4875","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recurrent device-related thrombosis after left atrial appendage closure with the watchman FLX: A case report and literature review","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology Cardiovascular Risk and Prevention","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcrp.2025.200527","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"200527"}}